Skip to main content

Triangle science firm beats the odds – extends Series A to $65M

Despite a collapse in life sciences funding, a new drug company with offices in Chapel Hill has raised millions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.